
Like traditional thinking about key opinion leaders (KOLs) in healthcare, consider the DOL as part of a marketing campaign

Like traditional thinking about key opinion leaders (KOLs) in healthcare, consider the DOL as part of a marketing campaign

Big Data analytics combined with fresh formulary data

Novartis, Pfizer and Roche will run neck-and-neck for global leader spot

Salesforce.com annual poll finds support for digital assistants and sharing health data

Context Matters Inc. and IHS Markit provide analytics on pricing strategies

Marketing strategies will adjust with the advent of biosimilars

An ‘overwhelming’ information load is affecting oncology’s ability to develop successful treatment pathways

Peer-to-peer network enables docs to discuss drug performance, especially of new launches

EMD Serono Specialty Digest finds they struggle over 'ensuring clinically appropriate use'

Less drug waste, fewer ER visits can offset high drug costs

Cutting Edge report finds continued growth in headcount


Despite the buzz around digital media channels, pharma continues to pour marketing dollars into television

Industry insider Nitin Sahney returns with PharmaCord

IPC and Pace Alliance will combine on April 1

LexisNexis Health Care analyzes affiliation data on healthcare providers

Drug-based therapies for opioid dependency gain acceptance and reimbursement

Interchangeability will require ‘switching studies’ and postmarketing surveillance

Brand manufacturers retain 47% of net expenditures for drugs

More hospital, but fewer practitioner deliveries

Healthcare providers occupy top three slots

First branded-product discount program from Blink Health

Growth rates will moderate in the US and world

Company offers to significantly undercut the pricing of sales force automation competitors

Company approaches one million sq. ft. of warehouse capacity for pharma sampling programs